17 research outputs found

    Π­ΠΊΡΠΏΠ΅Ρ€ΠΈΠΌΠ΅Π½Ρ‚Π°Π»ΡŒΠ½ΠΎΠ΅ исслСдованиС Π°Π½Ρ‚ΠΈΠ±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠ°Π»ΡŒΠ½ΠΎΠΉ активности литичСского стафилококкового Π±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠΎΡ„Π°Π³Π° ph20 ΠΈ литичСского Π±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠΎΡ„Π°Π³Π° синСгнойной ΠΏΠ°Π»ΠΎΡ‡ΠΊΠΈ ph57 ΠΏΡ€ΠΈ ΠΌΠΎΠ΄Π΅Π»ΠΈΡ€ΠΎΠ²Π°Π½ΠΈΠΈ ΠΈΡ… ΠΈΠΌΠΏΡ€Π΅Π³Π½Π°Ρ†ΠΈΠΈ Π² ортопСдичСскиС ΠΏΠΎΠ»ΠΈΠΌΠ΅Ρ€Π½Ρ‹Π΅ конструкции ΠΈΠ· ΠΏΠΎΠ»ΠΈΠΌΠ΅Ρ‚ΠΈΠ»ΠΌΠ΅Ρ‚Π°ΠΊΡ€ΠΈΠ»Π°Ρ‚Π° (костного Ρ†Π΅ΠΌΠ΅Π½Ρ‚Π°)

    Get PDF
    Background: The problem of bacterial colonization of implants used in medical practice continues to be relevant regardless of the material of the implant. Particular attention deserves polymeric implants, which are prepared ex tempore from polymethyl methacrylate, for example - duting orthopedic surgical interventions (so-called "bone cement"). The protection of such implants by antibiotic impregnation is subjected to multiple criticisms, therefore, as an alternative to antibiotics, lytic bacteriophages with a number of unique advantages can be used - however, no experimental studies have been published on the possibility of impregnating bacteriophages into polymethyl methacrylate and their antibacterial activity assessment under such conditions.Aims: to evaluate the possibility of physical placement of bacteriophages in polymethylmethacrylate and to characterize the lytic antibacterial effect of two different strains of bacteriophages when impregnated into polymer carrier ex tempore during the polymerization process in in vitro model.Materials and methods: Β First stage - Atomic force microscopy (AFM) of polymethyl methacrylate samples for medical purposes was used to determine the presence and size of caverns in polymethyl methacrylate after completion of its polymerization at various reaction Β temperatures (+6…+25Β°C and +18…+50Β°C).The second stage was performed in vitro and included an impregnation of two different bacteriophage strains (phage ph20 active against S. aureus and ph57 active against Ps. aeruginosa) into polymethyl methacrylate during the polymerization process, followed by determination of their antibacterial activity.Results: ACM showed the possibility of bacteriophages placement in the cavities of polymethyl methacrylate - the median of the section and the depth of cavities on the outer surface of the polymer sample polymerized at +18…+50Β°C were 100.0 and 40.0 nm, respectively, and on the surface of the transverse cleavage of the sample - 120.0 and 100.0 nm, respectively, which statistically did not differ from the geometric dimensions of the caverns of the sample polymerized at a temperature of +6…+25Β°C.The study of antibacterial activity showed that the ph20 bacteriophage impregnated in polymethyl methacrylate at +6…+25Β°C lost its effective titer within the first six days after the start of the experiment, while the phage ph57 retained an effective titer for at least 13 days.Conclusion: the study confirmed the possibility of bacteriophages impregnation into medical grade polymethyl methacrylate, maintaining the effective titer of the bacteriophage during phage emission into the external environment, which opens the way for the possible application of this method of bacteriophage delivery in clinical practice. It is also assumed that certain bacteriophages are susceptible to aggressive influences from the chemical components of "bone cement" and / or polymerization reaction products, which requires strict selection of bacteriophage strains that could be suitable for this method of delivery.ОбоснованиС. ΠŸΡ€ΠΎΠ±Π»Π΅ΠΌΠ° Π±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠ°Π»ΡŒΠ½ΠΎΠΉ ΠΊΠΎΠ»ΠΎΠ½ΠΈΠ·Π°Ρ†ΠΈΠΈ ΠΈΡΠΏΠΎΠ»ΡŒΠ·ΡƒΠ΅ΠΌΡ‹Ρ…Β Π²Β ΠΌΠ΅Π΄ΠΈΡ†ΠΈΠ½ΡΠΊΠΎΠΉ ΠΏΡ€Π°ΠΊΡ‚ΠΈΠΊΠ΅ ΠΈΠΌΠΏΠ»Π°Π½Ρ‚Π°Ρ‚ΠΎΠ² ΠΈΠ· Ρ€Π°Π·Π»ΠΈΡ‡Π½Ρ‹Ρ… ΠΌΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»ΠΎΠ² ΠΏΡ€ΠΎΠ΄ΠΎΠ»ΠΆΠ°Π΅Ρ‚ ΠΎΡΡ‚Π°Π²Π°Ρ‚ΡŒΡΡ Π°ΠΊΡ‚ΡƒΠ°Π»ΡŒΠ½ΠΎΠΉ, нСзависимо ΠΎΡ‚ использованного для ΠΈΡ… изготовлСния ΠΌΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»Π°. ΠžΡ‚Π΄Π΅Π»ΡŒΠ½ΠΎΠ³ΠΎ внимания Π·Π°ΡΠ»ΡƒΠΆΠΈΠ²Π°ΡŽΡ‚ ΠΈΠΌΠΏΠ»Π°Π½Ρ‚ΠΈΡ€ΡƒΠ΅ΠΌΡ‹Π΅Β Π²Β ΠΎΡ€Π³Π°Π½ΠΈΠ·ΠΌ Ρ‡Π΅Π»ΠΎΠ²Π΅ΠΊΠ° ΠΏΠΎΠ»ΠΈΠΌΠ΅Ρ€Π½Ρ‹Π΅ ΠΈΠΌΠΏΠ»Π°Π½Ρ‚Π°Ρ‚Ρ‹, ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Π΅ ΠΈΠ·Π³ΠΎΡ‚ΠΎΠ²Π»ΡΡŽΡ‚ exΒ tempore (ΠΏΠΎ ΠΌΠ΅Ρ€Π΅ надобности) ΠΈΠ· ΠΏΠΎΠ»ΠΈΠΌΠ΅Ρ‚ΠΈΠ»ΠΌΠ΅Ρ‚Π°ΠΊΡ€ΠΈΠ»Π°Ρ‚Π°, Π½Π°ΠΏΡ€ΠΈΠΌΠ΅Ρ€ ΠΏΡ€ΠΈ ортопСдичСских хирургичСских Π²ΠΌΠ΅ΡˆΠ°Ρ‚Π΅Π»ΡŒΡΡ‚Π²Π°Ρ… (Ρ‚Π°ΠΊ Π½Π°Π·Ρ‹Π²Π°Π΅ΠΌΡ‹ΠΉ костный Ρ†Π΅ΠΌΠ΅Π½Ρ‚). Π—Π°Ρ‰ΠΈΡ‚Π° Ρ‚Π°ΠΊΠΈΡ… ΠΈΠΌΠΏΠ»Π°Π½Ρ‚Π°Ρ‚ΠΎΠ² ΠΏΡƒΡ‚Π΅ΠΌ ΠΈΠΌΠΏΡ€Π΅Π³Π½Π°Ρ†ΠΈΠΈΒ Π²Β Π½ΠΈΡ… Π°Π½Ρ‚ΠΈΠ±ΠΈΠΎΡ‚ΠΈΠΊΠΎΠ² подвСргаСтся мноТСствСнной ΠΊΡ€ΠΈΡ‚ΠΈΠΊΠ΅, поэтому в качСствС Π°Π»ΡŒΡ‚Π΅Ρ€Π½Π°Ρ‚ΠΈΠ²Ρ‹ Π°Π½Ρ‚ΠΈΠ±ΠΈΠΎΡ‚ΠΈΠΊΠ°ΠΌ ΠΌΠΎΠ³ΡƒΡ‚ Π±Ρ‹Ρ‚ΡŒ ΠΈΡΠΏΠΎΠ»ΡŒΠ·ΠΎΠ²Π°Π½Ρ‹ литичСскиС Π±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠΎΡ„Π°Π³ΠΈ, ΠΎΠ±Π»Π°Π΄Π°ΡŽΡ‰ΠΈΠ΅ рядом ΡƒΠ½ΠΈΠΊΠ°Π»ΡŒΠ½Ρ‹Ρ… прСимущСств, ΠΎΠ΄Π½Π°ΠΊΠΎ ΡΠΊΡΠΏΠ΅Ρ€ΠΈΠΌΠ΅Π½Ρ‚Π°Π»ΡŒΠ½Ρ‹Ρ… Ρ€Π°Π±ΠΎΡ‚ ΠΏΠΎ ΠΈΠ·ΡƒΡ‡Π΅Π½ΠΈΡŽ возмоТности ΠΈΠΌΠΏΡ€Π΅Π³Π½Π°Ρ†ΠΈΠΈ Π±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠΎΡ„Π°Π³ΠΎΠ²Β Π²Β ΠΏΠΎΠ»ΠΈΠΌΠ΅Ρ‚ΠΈΠ»ΠΌΠ΅Ρ‚Π°ΠΊΡ€ΠΈΠ»Π°Ρ‚Β ΠΈΒ Π°Π½Ρ‚ΠΈΠ±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠ°Π»ΡŒΠ½ΠΎΠΉ активности в таких условиях в литСратурС Π½Π΅ ΠΎΠΏΡƒΠ±Π»ΠΈΠΊΠΎΠ²Π°Π½ΠΎ. ЦСль исслСдования ― ΠΈΠ·ΡƒΡ‡ΠΈΡ‚ΡŒ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡ‚ΡŒ физичСского размСщСния Π±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠΎΡ„Π°Π³ΠΎΠ²Β Π²Β ΠΏΠΎΠ»ΠΈΠΌΠ΅Ρ‚ΠΈΠ»ΠΌΠ΅Ρ‚Π°ΠΊΡ€ΠΈΠ»Π°Ρ‚Π΅Β ΠΈ Π²Β ΠΌΠΎΠ΄Π΅Π»ΠΈΒ inΒ vitroΒ ΠΎΡ…Π°Ρ€Π°ΠΊΡ‚Π΅Ρ€ΠΈΠ·ΠΎΠ²Π°Ρ‚ΡŒ литичСский Π°Π½Ρ‚ΠΈΠ±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠ°Π»ΡŒΠ½Ρ‹ΠΉ эффСкт Π΄Π²ΡƒΡ… Ρ€Π°Π·Π»ΠΈΡ‡Π½Ρ‹Ρ… ΡˆΡ‚Π°ΠΌΠΌΠΎΠ² Π±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠΎΡ„Π°Π³ΠΎΠ² ΠΏΡ€ΠΈ ΠΈΡ… ΠΈΠΌΠΏΡ€Π΅Π³Π½Π°Ρ†ΠΈΠΈΒ Π²Β ΠΈΠ·Π³ΠΎΡ‚Π°Π²Π»ΠΈΠ²Π°Π΅ΠΌΡ‹ΠΉ exΒ tempore ΠΏΠΎΠ»ΠΈΠΌΠ΅Ρ€Π½Ρ‹ΠΉ Π½ΠΎΡΠΈΡ‚Π΅Π»ΡŒ Π½Π° этапС ΠΏΠΎΠ»ΠΈΠΌΠ΅Ρ€ΠΈΠ·Π°Ρ†ΠΈΠΈ.Β ΠœΠ΅Ρ‚ΠΎΠ΄Ρ‹. ΠŸΠ΅Ρ€Π²Ρ‹ΠΌ этапом Π±Ρ‹Π»Π° ΠΏΡ€ΠΎΠ²Π΅Π΄Π΅Π½Π°Β Π°Ρ‚ΠΎΠΌΠ½ΠΎ-силовая микроскопия (АБМ) ΠΎΠ±Ρ€Π°Π·Ρ†ΠΎΠ² ΠΏΠΎΠ»ΠΈΠΌΠ΅Ρ‚ΠΈΠ»ΠΌΠ΅Ρ‚Π°ΠΊΡ€ΠΈΠ»Π°Ρ‚Π° мСдицинского назначСния для выяснСния наличия и размСров ΠΊΠ°Π²Π΅Ρ€Π½, ΠΎΠ±Ρ€Π°Π·ΠΎΠ²Π°Π²ΡˆΠΈΡ…ΡΡ послС Π·Π°Π²Π΅Ρ€ΡˆΠ΅Π½ΠΈΡ ΠΏΠΎΠ»ΠΈΠΌΠ΅Ρ€ΠΈΠ·Π°Ρ†ΠΈΠΈ ΠΏΡ€ΠΈ Ρ€Π°Π·Π»ΠΈΡ‡Π½ΠΎΠΌ Π΄ΠΈΠ°ΠΏΠ°Π·ΠΎΠ½Π΅ Ρ‚Π΅ΠΌΠΏΠ΅Ρ€Π°Ρ‚ΡƒΡ€ Ρ€Π΅Π°ΠΊΡ†ΠΈΠΎΠ½Π½ΠΎΠΉ смСси (+6…+25 Β°CΒ ΠΈΒ +18…+50 Β°C). Π’Ρ‚ΠΎΡ€Ρ‹ΠΌ этапом inΒ vitro Π±Ρ‹Π»ΠΎ ΠΏΡ€ΠΎΠ²Π΅Π΄Π΅Π½Π° импрСгнация Π΄Π²ΡƒΡ… Ρ€Π°Π·Π»ΠΈΡ‡Π½Ρ‹Ρ… ΡˆΡ‚Π°ΠΌΠΌΠΎΠ² Π±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠΎΡ„Π°Π³ΠΎΠ² (ph20, Π°ΠΊΡ‚ΠΈΠ²Π½ΠΎΠ³ΠΎΒ Π²Β ΠΎΡ‚Π½ΠΎΡˆΠ΅Π½ΠΈΠΈ StaphylococcusΒ aureus,Β ΠΈΒ ph57, Π°ΠΊΡ‚ΠΈΠ²Π½ΠΎΠ³ΠΎΒ Π²Β ΠΎΡ‚Π½ΠΎΡˆΠ΅Π½ΠΈΠΈ PseudomonasΒ aeruginosa)Β Π²Β ΠΏΠΎΠ»ΠΈΠΌΠ΅Ρ‚ΠΈΠ»ΠΌΠ΅Ρ‚Π°ΠΊΡ€ΠΈΠ»Π°Ρ‚ Π½Π° этапС ΠΏΠΎΠ»ΠΈΠΌΠ΅Ρ€ΠΈΠ·Π°Ρ†ΠΈΠΈΒ ΡΒ ΠΏΠΎΡΠ»Π΅Π΄ΡƒΡŽΡ‰ΠΈΠΌ ΠΎΠΏΡ€Π΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ΠΌ ΠΈΡ… Π°Π½Ρ‚ΠΈΠ±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠ°Π»ΡŒΠ½ΠΎΠΉ активности.Β Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹.Β Π’Β Ρ…ΠΎΠ΄Π΅ выполнСния АБМ установлСна Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡ‚ΡŒ размСщСния Π±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠΎΡ„Π°Π³ΠΎΠ²Β Π²Β ΠΊΠ°Π²Π΅Ρ€Π½Π°Ρ… ΠΏΠΎΠ»ΠΈΠΌΠ΅Ρ‚ΠΈΠ»ΠΌΠ΅Ρ‚Π°ΠΊΡ€ΠΈΠ»Π°Ρ‚Π°: ΠΌΠ΅Π΄ΠΈΠ°Π½Π° сСчСния и глубины ΠΊΠ°Π²Π΅Ρ€Π½ Π½Π° внСшнСй повСрхности ΠΎΠ±Ρ€Π°Π·Ρ†Π°, ΠΏΠΎΠ»ΠΈΠΌΠ΅Ρ€ΠΈΠ·ΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ ΠΏΡ€ΠΈ Ρ‚Π΅ΠΌΠΏΠ΅Ρ€Π°Ρ‚ΡƒΡ€Π΅ +18…+50 Β°C, составила 100,0Β ΠΈΒ 40,0Β Π½ΠΌ соотвСтствСнно,Β Π°Β Π½Π° повСрхности ΠΏΠΎΠΏΠ΅Ρ€Π΅Ρ‡Π½ΠΎΠ³ΠΎ скола образца ― 120,0Β ΠΈΒ 100,0Β Π½ΠΌ соотвСтствСнно, Ρ‡Ρ‚ΠΎ статистичСски Π½Π΅ ΠΎΡ‚Π»ΠΈΡ‡Π°Π»ΠΎΡΡŒ ΠΎΡ‚ гСомСтричСских Ρ€Π°Π·ΠΌΠ΅Ρ€ΠΎΠ² ΠΊΠ°Π²Π΅Ρ€Π½ ΠΎΠ±Ρ€Π°Π·Ρ†Π°, ΠΏΠΎΠ»ΠΈΠΌΠ΅Ρ€ΠΈΠ·ΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ ΠΏΡ€ΠΈ Ρ‚Π΅ΠΌΠΏΠ΅Ρ€Π°Ρ‚ΡƒΡ€Π΅ +6…+25 Β°C. Π˜Π·ΡƒΡ‡Π΅Π½ΠΈΠ΅ Π°Π½Ρ‚ΠΈΠ±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠ°Π»ΡŒΠ½ΠΎΠΉ активности ΠΏΠΎΠΊΠ°Π·Π°Π»ΠΎ, Ρ‡Ρ‚ΠΎ ΠΈΠΌΠΏΡ€Π΅Π³Π½ΠΈΡ€ΠΎΠ²Π°Π½Π½Ρ‹ΠΉ ΠΏΡ€ΠΈ +6…+25 Β°CΒ Π²Β ΠΏΠΎΠ»ΠΈΠΌΠ΅Ρ‚ΠΈΠ»ΠΌΠ΅Ρ‚Π°ΠΊΡ€ΠΈΠ»Π°Ρ‚ стафилококковый Π±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠΎΡ„Π°Π³Β ph20 ΡƒΡ‚Ρ€Π°Ρ‚ΠΈΠ» эффСктивный Ρ‚ΠΈΡ‚Ρ€ ΡƒΠΆΠ΅Β Π²Β Ρ‚Π΅Ρ‡Π΅Π½ΠΈΠ΅ ΠΏΠ΅Ρ€Π²Ρ‹Ρ… ΡˆΠ΅ΡΡ‚ΠΈ суток с момСнта Π½Π°Ρ‡Π°Π»Π° экспСримСнта, Ρ‚ΠΎΠ³Π΄Π° ΠΊΠ°ΠΊ синСгнойный Π±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠΎΡ„Π°Π³Β ph57 сохранял эффСктивный Ρ‚ΠΈΡ‚Ρ€ ΠΊΠ°ΠΊ ΠΌΠΈΠ½ΠΈΠΌΡƒΠΌΒ Π²Β Ρ‚Π΅Ρ‡Π΅Π½ΠΈΠ΅ 13 сут.Β Π—Π°ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠ΅. В исслСдовании Π±Ρ‹Π»Π° ΠΏΠΎΠ΄Ρ‚Π²Π΅Ρ€ΠΆΠ΄Π΅Π½Π° Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡ‚ΡŒ ΠΈΠΌΠΏΡ€Π΅Π³Π½Π°Ρ†ΠΈΠΈ Π±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠΎΡ„Π°Π³ΠΎΠ²Β Π²Β ΠΏΠΎΠ»ΠΈΠΌΠ΅Ρ‚ΠΈΠ»ΠΌΠ΅Ρ‚Π°ΠΊΡ€ΠΈΠ»Π°Ρ‚ мСдицинского назначСния с поддСрТаниСм эффСктивного Ρ‚ΠΈΡ‚Ρ€Π° Π±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠΎΡ„Π°Π³Π° ΠΏΡ€ΠΈ Π΅Π³ΠΎ эмиссии Π²ΠΎ внСшнюю срСду, Ρ‡Ρ‚ΠΎ ΠΎΡ‚ΠΊΡ€Ρ‹Π²Π°Π΅Ρ‚ ΠΏΡƒΡ‚ΠΈ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΠ³ΠΎ примСнСния Ρ‚Π°ΠΊΠΎΠ³ΠΎ способа доставки бактСриофагов в клиничСской ΠΏΡ€Π°ΠΊΡ‚ΠΈΠΊΠ΅. Π’Π°ΠΊΠΆΠ΅ сдСланы прСдполоТСния о вСроятной подвСрТСнности Π½Π΅ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Ρ… Π±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠΎΡ„Π°Π³ΠΎΠ² агрСссивным воздСйствиям со стороны химичСских ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½Ρ‚ΠΎΠ² «костного Ρ†Π΅ΠΌΠ΅Π½Ρ‚Π°Β» ΠΈ/ΠΈΠ»ΠΈ ΠΏΡ€ΠΎΠ΄ΡƒΠΊΡ‚ΠΎΠ² Ρ€Π΅Π°ΠΊΡ†ΠΈΠΈ ΠΏΠΎΠ»ΠΈΠΌΠ΅Ρ€ΠΈΠ·Π°Ρ†ΠΈΠΈ, Ρ‡Ρ‚ΠΎ Ρ‚Ρ€Π΅Π±ΡƒΠ΅Ρ‚ строгого ΠΎΡ‚Π±ΠΎΡ€Π° ΠΏΡ€ΠΈΠ³ΠΎΠ΄Π½Ρ‹Ρ… для ΠΏΠΎΠ΄ΠΎΠ±Π½ΠΎΠ³ΠΎ способа доставки ΡˆΡ‚Π°ΠΌΠΌΠΎΠ² Π±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠΎΡ„Π°Π³ΠΎΠ²

    Phase transition in waters with different content of deuterium

    No full text
    According to kinetics of temperature changes and laser light scattering on density heterogeneities we investigated waters with different content of deuterium in the area of their phase transition. It has been found out that protium/deuterium ratio substantially affects the process of phase transition water-ice-water in non-equilibrium conditions (the rate of temperature changesβ€”2Β°C/min): temperature of light water ice melting (D/H = 4.2 ppm) constitutes 1.1 Β± 0.3Β°C against 0.0 Β± 0.3Β°C for high ohmic deionized water (D/H = 140 ppm) and 3.8 Β± 0.3Β°Cβ€”for heavy one. Determined are special features of changes in phase state of water on the basis of concepts about water as a colloid system containing deuterium and stabilized gigantic heterophase clusters. Β© 2015, Allerton Press, Inc

    Phase transition in waters with different content of deuterium

    No full text
    According to kinetics of temperature changes and laser light scattering on density heterogeneities we investigated waters with different content of deuterium in the area of their phase transition. It has been found out that protium/deuterium ratio substantially affects the process of phase transition water-ice-water in non-equilibrium conditions (the rate of temperature changesβ€”2Β°C/min): temperature of light water ice melting (D/H = 4.2 ppm) constitutes 1.1 Β± 0.3Β°C against 0.0 Β± 0.3Β°C for high ohmic deionized water (D/H = 140 ppm) and 3.8 Β± 0.3Β°Cβ€”for heavy one. Determined are special features of changes in phase state of water on the basis of concepts about water as a colloid system containing deuterium and stabilized gigantic heterophase clusters. Β© 2015, Allerton Press, Inc

    Experience in the correction of genital prolapse with laparoscopic lateral suspension in patients underwent total or subtotal hysterectomy

    No full text
    Experience in the correction of genital prolapse with laparoscopic lateral suspension in patients underwent total or subtotal hysterectomy M.V. Gavrilov1,2, I.A. Lapina1,2, V.V. Taranov1, T.G. Koltinova1 1Pirogov Russian National Research Medical University, Moscow, Russian Federation 2Group of companies Β«MedsiΒ», Moscow, Russian Federation Genital prolapse (GP) is still an important issue of modern gynecology. Advances in treatment approaches to this disorder based on its severity and many other factors are reported every year. Patients and Methods: 36 women with verified apical genital prolapse (i.e., 24 women with posthysterectomy vaginal vault prolapse and 12 women with genital prolapse after supracervical hysterectomy) were enrolled in the study. At admission, the most common complaints were foreign body sensation in the perineum (31 women, 86%), dyspareunia (10 women, 28%), and obstructed defecation (6 women, 17%). 34 women (94%) had vaginal delivery. POP-Q system was used to stage pelvic organ prolapse. POP-Q stage 2 was diagnosed in 16.7%, stage 3 in 38.9%, and stage 4 in 44.4%. All women underwent laparoscopic lateral suspension with mesh. Results: 6 and 12 months after the surgery, no recurrent genital prolapse was diagnosed by gynecological (vaginal) examination and pelvic ultrasound. The quality of life assessed by the PFIQ-7 questionnaire has improved (19.8Β±3.7). Sexual activity assessed by the PISQ-12 questionnaire has significantly improved (20.1Β±2.4). Conclusion: laparoscopic lateral suspension with synthetic mesh is an effective, simple, and safe technique for genital prolapse surgery. This procedure provides minimal early and late postoperative complications and significantly improves the qulity of life. Key words: sacrocolpopexy, laparoscopic lateral suspension, genital prolapse, apical prolapse, mesh implant, mesh erosion. For citation: Gavrilov M.V., Lapina I.A., Taranov V.V., Koltinova T.G. Experience in the correction of genital prolapse with laparoscopic lateral suspension in patients underwent total or subtotal hysterectomy. Russian Journal of Woman and Child Health. 2019;2(1):28–32.<br

    New prospects of the integrative therapy for polycystic ovary syndrome in women with the disorders of carbohydrate and lipid metabolism: a comparative study.

    No full text
    Yu.E.&nbsp;Dobrokhotova, I.A.&nbsp;Lapina, T.G.&nbsp;Chirvon, V.V.&nbsp;Taranov Pirogov Russian National Research Medical University, Moscow, Russian Federation Background: long-term combined estrogen-progestin oral contraceptive pills (COCPs) are the first-line treatment for polycystic ovary syndrome (PCOS). However, this therapeutic option does not affect metabolic disorders that are more severe in women with the second PCOS phenotype thus increasing the risk of cardiometabolic complications. Aim: to assess the effect of myo-inositol and D-chiro-inositol at a 5:1 ratio on metabolic parameters in women of reproductive age with the second PCOS pathogenetic type and the disorders of carbohydrate and lipid metabolism. Patients and Methods: 60 overweight and obese women with PCOS were enrolled in this randomized prospective study. Group 1 women (n=30) received COCP and a drug containing two isoforms of inositol at a 5:1 ratio (myo-inositol 1,000 mg plus D-chiro inositol 200 mg). Group 2 women (n = 30) received COCP only. Hemostasis, lipid panel, fasting glucose level, body mass index (BMI), and waist circumference were measur ed before and 90 days after treatment begins. Results: in group 1, the significant (p&lt;0.05) improvement of lipid parameters was reported as demonstrated by the reduction of the levels of total cholesterol (TC) by 16.9%, triglycerides by 15.7%, low-density lipoprotein cholesterol (LDL–C) by 17.8%, fibrinogen by 15.8%, and fasting glucose by 16.9% as well as the increase of high-density lipoprotein cholesterol (HDL–C) by 28.5%. Meanwhile, no significant changes were seen in group 2. Additionally, the reduction of waist circumference by 4.5% and BMI by 9.1% was reported in group 1. Conclusions: a medication containing myo-inositol and D-chiro-inositol at a 5:1 ratio is promising for the prevention of cardiometabolic complications in women with PCOS. Further large studies of the investigated drug are needed to demonstrate its efficacy and to assess its properties. Keywords: polycystic ovary syndrome (PCOS), treatment, prevention, obesity, metabolic syndrome, lipid panel, inositol, oral contraceptive pills. For citation: Dobrokhotova Yu.E., Lapina I.A., Chirvon T.G., Taranov V.V. New prospects of the integrative therapy for polycystic ovary syndrome in women with the disorders of carbohydrate and lipid metabolism: a comparative study. Russian Journal of Woman and Child Health. 2020;3(3):169–173. DOI: 10.32364/2618-8430-2020-3-3-169-173. </p

    Pre-pregnancy preparation in women with polycystic ovary syndrome and obesity: state-of-the-art

    No full text
    I.A.&nbsp;Lapina, T.G.&nbsp;Chirvon, Yu.E. Dobrokhotova, V.V.&nbsp;Taranov Pirogov Russian National Research Medical University, Moscow, Russian Federation In recent decades, extensive growth in the number of overweight or obese individuals is reported thus making this issue important for the medical community. According to some authors, 8% of overweight women and 18% of obese women have troubles with realizing reproductive function. Glucose and lipid metabolism disorders and hypertension that are common in women with polycystic ovary syndrome (PCOS) allow for referring this condition to metabolic diseases. Metabolic syndrome is an umbrella term for a set of metabolic abnormalities arising from insulin resistance and hyperinsulinemia. PCOS may also be considered as one of its manifestations being regarded as the most common cause of infertility in overweight and obese women. The treatment should be complex to recover reproductive function and to address metabolic disorders. Adherence to lifestyle changes, diet, and regular physical activity is still poor. Therefore, the use and assessment of the efficacy of pharmaceutical s for pre-pregnancy preparation to lose weight and to improve reproductive outcomes in PCOS. Keywords: polycystic ovary syndrome, PCOS, obesity, metabolic syndrome, infertility, pre-pregnancy preparation, treatment, prevention, ovulation. For citation: Lapina I.A., Chirvon T.G., Dobrokhotova Yu.E., Taranov V.V. Pre-pregnancy preparation in women with polycystic ovary syndrome and obesity: state-of-the-art. Russian Journal of Woman and Child Health. 2021;4(2):137–143. DOI: 10.32364/2618-8430-2021-4-2-137-143. </p

    ΠœΠ•Π’ΠžΠ” Π”Π’Π£ΠœΠ•Π ΠΠžΠ“Πž Π”Π˜ΠΠΠœΠ˜Π§Π•Π‘ΠšΠžΠ“Πž Π‘Π’Π•Π’ΠžΠ ΠΠ‘Π‘Π•Π―ΠΠ˜Π― Π”Π›Π― ΠžΠŸΠ Π•Π”Π•Π›Π•ΠΠ˜Π― ΠŸΠžΠ”Π›Π˜ΠΠΠžΠ‘Π’Π˜ ΠœΠΠ’Π•Π Π˜ΠΠ›ΠžΠ’ И Π›Π•ΠšΠΠ Π‘Π’Π’Π•ΠΠΠ«Π₯ Π‘Π Π•Π”Π‘Π’Π’

    No full text
    A method of two-dimensional dynamic backscattering (2D-DLS) with data processing according to a mathematical model of topological descriptors is proposed. The set of topological descriptors makes it possible to fingerprint of the surface, which is in one-to-one correspondence with the chemical composition and the method of its preparation. The 2D-DLS method was introduced at a pharmaceutical enterprise to control powdered medicinal substances obtained in fluidized bed chambers, as well as at two plants for the production of water with a modified isotopic composition for operational control of drugs in terms of the performance of distillation columns in terms of "authenticity".ΠŸΡ€Π΅Π΄Π»ΠΎΠΆΠ΅Π½ ΠΌΠ΅Ρ‚ΠΎΠ΄ Π΄Π²ΡƒΠΌΠ΅Ρ€Π½ΠΎΠ³ΠΎ динамичСского ΠΎΠ±Ρ€Π°Ρ‚Π½ΠΎΠ³ΠΎ свСторассСяния (2D-DLS) с ΠΎΠ±Ρ€Π°Π±ΠΎΡ‚ΠΊΠΎΠΉ Π΄Π°Π½Π½Ρ‹Ρ… ΠΏΠΎ матСматичСской ΠΌΠΎΠ΄Π΅Π»ΠΈ топологичСских дСскрипторов. ΠœΠ΅Ρ‚ΠΎΠ΄ основан Π½Π° ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠΈ Ρ‚ΠΎΠΏΠΎΠ»ΠΎΠ³ΠΈΠΈ свСторассСяния ΠΎΡ‚ повСрхности ΠΏΡ€ΠΈ низкочастотном колСбаниях супрамолСкулярных комплСксов. Набор дСскрипторов позволяСт Ρ„ΠΎΡ€ΠΌΠΈΡ€ΠΎΠ²Π°Ρ‚ΡŒ Ρ„ΠΈΠ½Π³Π΅Ρ€ΠΏΡ€ΠΈΠ½Ρ‚ повСрхности, находящийся Π²ΠΎ Π²Π·Π°ΠΈΠΌΠ½ΠΎ-ΠΎΠ΄Π½ΠΎΠ·Π½Π°Ρ‡Π½ΠΎΠΌ соотвСтствии с химичСским составом ΠΈ способом Π΅Π³ΠΎ приготовлСния. ΠœΠ΅Ρ‚ΠΎΠ΄ 2D-DLS Π²Π½Π΅Π΄Ρ€Π΅Π½ Π½Π° фармацСвтичСском прСдприятии для контроля ΠΏΠΎΡ€ΠΎΡˆΠΊΠΎΠΎΠ±Ρ€Π°Π·Π½Ρ‹Ρ… лСкарствСнных вСщСств, ΠΏΠΎΠ»ΡƒΡ‡Π°Π΅ΠΌΡ‹Ρ… Π² ΠΊΠ°ΠΌΠ΅Ρ€Π°Ρ… псСвдооТиТСнного слоя, Π° Ρ‚Π°ΠΊΠΆΠ΅ Π½Π° Π΄Π²ΡƒΡ… Π·Π°Π²ΠΎΠ΄Π°Ρ… ΠΏΠΎ производству Π²ΠΎΠ΄Ρ‹ с ΠΈΠ·ΠΌΠ΅Π½Π΅Π½Π½Ρ‹ΠΌ ΠΈΠ·ΠΎΡ‚ΠΎΠΏΠ½Ρ‹ΠΌ составом для ΠΎΠΏΠ΅Ρ€Π°Ρ‚ΠΈΠ²Π½ΠΎΠ³ΠΎ контроля ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚ΠΎΠ²

    Sleep latency in poor nappers under exposure to weak 2-Hz and 8-Hz electromagnetic fields

    No full text
    It was hypothesized that human sleep might respond to the fields emitted by such natural sources as magnetic activity of the sun and the earth’s magnetic fields. However, the experiments aimed on testing this hypothesis remain scarce. Previously, we found an increase in the amounts of stages N2 or N3 during napping of good sleepers under exposure to low-level (0.004 ΞΌT) electromagnetic fields of frequencies 1Β Hz or 2Β Hz. It remains unexplored whether these fields might additionally decrease latency to stage N1. In this study, we selected 13 people with falling asleep problems to examine the effects of low-level electromagnetic fields on sleep latency. Sleep of these study participants was polysomnographically recorded during three 50-min afternoon napping attempts, either with exposure to either 2Β Hz/0.004 ΞΌT or 8Β Hz/0.004 ΞΌT electromagnetic fields or without exposure. We did not find that the sham exposure differed from the 2Β Hz and 8Β Hz exposures in latency to N1, while latency to N2 after the sham exposure was even shorter than after either the 2Β Hz or 8Β Hz exposure. We concluded that, although the effects of tested fields might be beneficial for sleep intensity (e.g., due to prolongation of N3), they might not be additionally effective against the falling asleep problems. Β© 2021 Informa UK Limited, trading as Taylor & Francis Group

    An hour in the morning is worth two in the evening: association of morning component of morningness–eveningness with single nucleotide polymorphisms in circadian clock genes

    No full text
    Sub-constructs of morning–evening preference might be differentially related to polymorphisms in circadian clock genes. We previously reported significant association between a single nucleotide polymorphism in PER3 (rs2640909) and Morning but not Evening Lateness scale of the Sleep–Wake Pattern Assessment Questionnaire. To further explore such a scale-specific relationship, seven single nucleotide polymorphisms in five circadian clock genes were studied using exploratory and confirmatory samples (in total, nΒ =Β 698). The association of rs2640909 with Morning Lateness scale was not replicated in the confirmatory sample but remained significant in the merged sample. Moreover, we found and confirmed an association of this scale with rs1159814 in RORΞ±. The results provided further evidence for differential relationship of polymorphisms in circadian clock genes with morning and evening components of morning–evening preference. We also suggested possibility to take into account the pattern of geographic variation in allele frequency for prioritization of circadian clock polymorphisms in candidate gene studies. Β© 2017 Informa UK Limited, trading as Taylor & Francis Group

    Effects of exposures to weak 2-Hz vs. 8-Hz electromagnetic fields on spectral characteristics of the electroencephalogram in afternoon nap

    No full text
    The human brain seems to be able to respond to low-level extremely low-frequency electromagnetic fields. Controlled laboratory studies of human sleep under exposure to such fields are scarce, especially on the effects of 1Β Hz–16Β Hz fields overlapping with the frequencies of the electroencephalographic (EEG) signal (e.g., delta, theta, alpha, and sigma activities). In a double-blind placebo-controlled study, we examined the effects of exposure to low-level electromagnetic fields of frequencies 2Β Hz and 8Β Hz on the EEG power density spectra in the range from 1Β Hz to 16Β Hz and sleep structure. Sleep of 14 young healthy volunteers was polysomnographically recorded during three 50-min afternoon naps (either without exposure or with 2Β Hz/0.004 ΞΌT or 8Β Hz/0.004 ΞΌT electromagnetic field). During the first 30Β min of a nap the sham, 2Β Hz or 8Β Hz/0.004 ΞΌT exposures had the same effect. For the remaining 20Β min, amount of stage 3 sleep and powers in 1Β Hz-8Β Hz range continued to build up under the 8Β Hz/0.004ΞΌT and, especially, under the 2Β Hz/0.004 ΞΌT exposure, whereas they did not change in the sham condition. Therefore, the low-level 2Β Hz electromagnetic fields might stimulate deep sleep in the afternoon nap. Β© 2020 Informa UK Limited, trading as Taylor & Francis Group
    corecore